title: Triptans: do they differ?
abstract: Headache care specialists agree that the introduction of sumatriptan constitutes a major advance in headache therapy, but they differ about whether other triptans offer clinically significant advantages over sumatriptan. This article examines this issue by considering the similarities and differences among triptans.
authors.affiliation: GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 27709, USA. as23589@gsk.com
authors.forename: Reijo
authors.initials: R
authors.lastname: Salonen
authors.forename: Andrew
authors.initials: A
authors.lastname: Scott
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods / Q000706:statistics & numerical data; D004304:Dosage Forms; D006261:Headache / Q000188:drug therapy; D006801:Humans; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000493:pharmacokinetics; D018170:Sumatriptan / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D004304:Dosage Forms; D017366:Serotonin Receptor Agonists; D018170:Sumatriptan